Malaria Information and Prophylaxis, by Country [V]

The information presented in this table is consistent 1 with the information in the CDC Health Information for International Travel (the “Yellow Book”).

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Malaria Information and Prophylaxis by Country
Country Areas with Malaria Drug Resistance2 Malaria Species3 Recommended Chemoprophylaxis4 Key Information Needed and Helpful Links to Assess Need for Prophylaxis for Select Countries
Vanuatu All Chloroquine P. falciparum 60%,

P. vivax 35-40%,

P. ovale <1%

Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6
Venezuela All areas at altitudes < 1,700 m (5,577 ft). Present in Angel Falls. Chloroquine P. vivax 83%,

P. falciparum 17%

Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6
Vietnam Rural areas only. Rare cases in the Mekong and Red River Deltas. None in the cities of Da Nang, Haiphong, Hanoi, Ho Chi Minh (Saigon), Nha Trang, and Qui Nhon. Chloroquine
and
Mefloquine
P. falciparum 50-90%,

P. vivax 10-50%,

P. knowlesi rare

Southern part of the country in the provinces of Dac Lac, Gia Lai, Khanh Hoa, Kon Tum, Lam Dong, Ninh Thuan, Song Be, Tay Ninh: Atovaquone-proguanil, doxycycline, or tafenoquine6.
Other areas with malaria except Mekong and Red River Deltas: Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6.
Mekong and Red River Deltas: Mosquito avoidance only.
Virgin Islands, British None Not Applicable Not Applicable Not Applicable
Virgin Islands, U.S. None Not Applicable Not Applicable Not Applicable

1. Factors that affect local malaria transmission patterns can change rapidly and from year to year, such as local weather conditions, mosquito vector density, and prevalence of infection. Information in these tables is updated regularly.
2. Refers to P. falciparum malaria unless otherwise noted.
3. Estimates of malaria species are based on best available data from multiple sources.
4. Several medications are available for chemoprophylaxis. When deciding which drug to use, consider specific itinerary, length of trip, cost of drug, previous adverse reactions to antimalarials, drug allergies, and current medical history. All travelers should seek medical attention in the event of fever during or after return from travel to areas with malaria.
5. This risk estimate is based largely on cases occurring in US military personnel who travel for extended periods of time with unique itineraries that likely do not reflect the risk for the average US traveler.
6. Primaquine and tafenoquine can cause hemolytic anemia in persons with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Patients must be screened for G6PD deficiency prior to starting primaquine.

Page last reviewed: March 27, 2019